Robotics medical tech company Vicarious Surgical announced that shareholders of D8 Holdings approved the companies’ business combination, which is expected to close Sept. 17.
The deal is expected to provide approximately $220 million in gross proceeds to Vicarious. The company was originally expected to receive $487 million.
D8 in an 8-K filing disclosed that 26,745,028 Class A ordinary shares were redeemed, leaving approximately $77.55 million in trust.
The SPAC announced last week it had shored up additional PIPE commitments to satisfy the minimum $125 million cash condition for closing the deal.
Following the close of the transaction, Vicarious Surgical stock and warrants are expected to begin trading SEpt. 20 on the NYSE under RBOT and RBOT WS. Read more.
